BETHANY TAYLOR: Open Payments
NPI 1770043051 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 42 payments from 15 companies in 2025. Trend: 2023 $480 · 2024 $616 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $175 |
| Novo Nordisk Inc | 9 | $141 |
| Merck Sharp & Dohme LLC | 3 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Tactile Systems Technology Inc | 3 | $60 |
| Exact Sciences Corporation | 3 | $58 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Lilly USA, LLC | 1 | $28 |
| Abbott Laboratories | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
Products named: NURTEC ODT, GARDASIL 9, Ozempic, ELIQUIS, Flexitouch Plus, The Cologuard Plus Collection Kit, Wegovy, Rybelsus.
Industry payments across MD — which companies pay providers there.
